Bio Special BioInvest
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion
As in prior funds, Fund VIII was oversubscribed and reached its hard cap for limited partner commitments. This increases the firm's capital raised to ...
July 12, 2022 | News
Capnopharm announces asset purchase of Capnomed to continue work on peritoneal cancer
Capnopharm GmbH announced it has entered into an asset purchase agreement to acquire all operating assets from Capnomed GmbH.Founded in 2015, Capnomed ha...
July 11, 2022 | News
BRIM Biotechnology enters OTC trading in Taiwan
Established in July 2013, BRIM is a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative j...
June 24, 2022 | News
Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials
Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion...
June 23, 2022 | News
Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results
Revenue of $1.61 billion represents 5% reported growth; and up 7% on a core(1) basis. GAAP net income of $274 million with earnings per...
June 21, 2022 | News
Merck Places Bonds Amounting to €1.0 billion
Merck, a leading science and technology company, issued bonds amounting to € 1.0 billion. The revenue from the bond issue will be used for gener...
June 20, 2022 | News
META raised 15M USD to accelerate its pipeline development
META Pharmaceuticals, China's first immunometabolism-based small-molecule drug discovery company, announced two consecutive Seed and Pre-A fundin...
June 14, 2022 | News
BD To Acquire Parata Systems To Enter New Pharmacy Automation Solutions Market
Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings...
June 07, 2022 | News
Brii Biosciences to be Added to MSCI China Small Cap Index
The MSCI China Small Cap Index is an equity index compiled by MSCI Inc., a leading provider of critical decision support tools and services for the global ...
May 25, 2022 | News
Merck Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland
Company to invest in two major Life Science projects over five years Significantly increases membrane manufacturing capacities and enables construction ...
May 23, 2022 | News
Pharma companies with ESG more valuable say investors
This is backed up by the 2020 Edelman annual survey, which found that 88% of institutional investors believe that companies who prioritise ESG in...
May 20, 2022 | News
Kintor Pharma Included in MSCI China Index
The MSCI series index is a stock index compiled by Morgan Stanley Capital International. It is one of the most influential stock indexes in the world and o...
May 16, 2022 | News
Merck Delivers Strong First Quarter
Results of Q1 2022 Group sales increase by 12.2% to € 5.2 billion; EBITDA pre up 7.8% to € 1.6 billion; EBITDA pre margin 31.3% Growth story ...
May 13, 2022 | News
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers
InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug r...
May 09, 2022 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
